CCM
Camber Capital Management Portfolio holdings
AUM
$718M
1-Year Est. Return
8.19%
This Fund
S&P 500
1 Year Est. Return
-8.19%
AUM
$1.6B
AUM Growth
-$954M
(-37%)
Holding
38
Top Buys
| 1 | +$69M | |
| 2 | +$36.8M | |
| 3 | +$20.3M | |
| 4 |
Cigna
CI
|
+$15.1M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$3.36M |
Top Sells
| 1 | +$220M | |
| 2 | +$142M | |
| 3 | +$91.5M | |
| 4 |
PTC Therapeutics
PTCT
|
+$84.8M |
| 5 |
Viatris
VTRS
|
+$78.7M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Zimmer Biomet
ZBH
$18.2B
| $255M | 15.89% |
2,250,000
+645,000
|
|
||
2
Baxter International
BAX
$8.95B
| $197M | 12.28% |
5,750,000
+1,125,000
|
|
||
3
Humana
HUM
$19.9B
| $192M | 11.97% |
725,000
+75,000
|
|
||
4
CVS Health
CVS
$96.9B
| $152M | 9.51% |
2,250,000
-750,000
|
|
||
5
Globus Medical
GMED
$11.5B
| $91.5M | 5.71% |
1,250,000
+25,000
|
|
||
|
6
PTC Therapeutics
PTCT
$5.34B
| $76.4M | 4.77% |
1,500,000
-1,700,000
|
|
||
|
7
Cigna
CI
$70.4B
| $65.8M | 4.11% |
200,000
+50,000
|
|
||
|
8
Viatris
VTRS
$15.6B
| $65.3M | 4.08% |
7,500,000
-7,500,000
|
|
||
9
Pfizer
PFE
$151B
| $63.4M | 3.95% |
2,500,000
-2,500,000
|
|
||
10
Qiagen
QGEN
$8.37B
| $56.2M | 3.51% |
1,400,000
-58,333
|
|
||
11
Ascendis Pharma
ASND
$13.9B
| $54.6M | 3.4% |
350,000
-450,000
|
|
||
12
Sarepta Therapeutics
SRPT
$1.72B
| $51.1M | 3.19% |
800,000
-200,000
|
|
||
13
Brookdale Senior Living
BKD
$3.32B
| $39.1M | 2.44% |
6,250,000
-7,685,000
|
|
||
|
14
BioMarin Pharmaceuticals
BMRN
$11.3B
| $35.3M | 2.21% |
500,000
+50,000
|
|
||
|
CON
15
Concentra Group Holdings
CON
$2.88B
| $34.7M | 2.17% |
1,600,000
-1,900,000
|
|
||
16
Evolent Health
EVH
$334M
| $28.4M | 1.77% |
3,000,000
-1,000,000
|
|
||
17
Ionis Pharmaceuticals
IONS
$11.8B
| $21.9M | 1.36% |
725,000
+100,000
|
|
||
18
Myriad Genetics
MYGN
$436M
| $20.8M | 1.3% |
2,350,000
-750,000
|
|
||
|
ZIMV
19
DELISTED
ZimVie
ZIMV
| $20.4M | 1.27% |
1,885,000
-840,000
|
|
||
20
MoonLake Immunotherapeutics
MLTX
$1.23B
| $17.2M | 1.08% |
441,000
|
|
||
21
Denali Therapeutics
DNLI
$3.26B
| $17M | 1.06% |
1,250,000
-1,000,000
|
|
||
22
AnaptysBio
ANAB
$1.86B
| $13.9M | 0.87% |
750,000
-500,000
|
|
||
23
Theravance Biopharma
TBPH
$698M
| $8.93M | 0.56% |
1,000,000
|
|
||
24
10x Genomics
TXG
$2.4B
| $8.73M | 0.54% |
1,000,000
|
|
||
25
Inogen
INGN
$165M
| $6.95M | 0.43% |
975,000
-1,025,000
|
|